share

Quinoxaline, 5,8-Dibromo-6-Fluoro-2,3-Bis[3-(Octyloxy)Phenyl]- CAS NO 1415800-22-4


Unit Price:

CAS No.:1415800-22-4

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

Quinoxaline, 5,8-Dibromo-6-Fluoro-2,3-Bis[3-(Octyloxy)Phenyl]- is a high-value, multi-substituted quinoxaline derivative designed for advanced material science and pharmaceutical research. This compound matters for its role as a sophisticated organic semiconductor precursor and a versatile pharmaceutical intermediate, offering tunable electronic properties through its unique halogenated and alkoxy-substituted structure. It is critically needed by R&D teams and production chemists in the organic electronics and fine chemical synthesis sectors.

Application

  • Organic Light-Emitting Diodes (OLEDs): Serves as a key building block for electron-transport materials (ETMs) or host materials in emissive layers.
  • Organic Photovoltaics (OPVs): Used in the synthesis of novel donor or acceptor materials for solar cell applications.
  • Pharmaceutical Intermediates: Acts as a complex scaffold in the research and development of new active pharmaceutical ingredients (APIs), particularly for targeted therapies.
  • Agrochemical Research: Employed in creating novel compounds with potential biological activity for crop protection.
  • Material Science Research: Utilized in developing advanced polymers, liquid crystals, or sensors due to its rigid, planar quinoxaline core and solubilizing side chains.
  • Academic & Industrial R&D: A valuable reagent for synthetic chemists exploring novel heterocyclic chemistry and structure-property relationships.

Basic Information

Product Name Quinoxaline, 5,8-Dibromo-6-Fluoro-2,3-Bis[3-(Octyloxy)Phenyl]-
CAS No. 1415800-22-4
Molecular Formula C38H48Br2FNO2
Molecular Weight 737.61 g/mol
Synonyms 5,8-Dibromo-6-fluoro-2,3-bis[3-(octyloxy)phenyl]quinoxaline; 2,3-Bis(3-octyloxyphenyl)-5,8-dibromo-6-fluoroquinoxaline; DBFOBOP-Quinoxaline; Quinoxaline derivative, DBF-2,3-di(3-octyloxyphenyl)-5,8-dibromo-6-fluoro; Light-emitting material intermediate 1415800-22-4
EINECS Contact for details

Quality Control

Every batch of our Quinoxaline derivative is synthesized and purified under controlled conditions to meet the stringent requirements of advanced research and development. We employ advanced analytical techniques, including HPLC, NMR, and Mass Spectrometry, to ensure identity, purity, and lot-to-lot consistency. A comprehensive Certificate of Analysis (COA) detailing all specifications is provided with each shipment to support your quality assurance protocols.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). The compound is light-sensitive; prolonged exposure to light should be avoided to maintain stability.

Specification

Item Specification
Appearance Off-white to light yellow crystalline powder
Identification (IR) Conforms to structure
Identification (NMR) Conforms to structure
Purity (HPLC) ≥ 97.0%
Loss on Drying ≤ 0.5%
Residue on Ignition ≤ 0.1%
Heavy Metals ≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

Why choose US

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.